Theranos used to be one of the hottest names in Silicon Valley. Theranos and its founder and CEO, Elizabeth Holmes, were equally buzzy. This was due mostly to the company’s near-revolutionary blood-testing machine.
In the past six months or so, though, a good part of the shine has worn off.
Theranos’s testing results have come under serious scrutiny, and there was a new and troubling development Thursday. The “Wall Street Journal” reports that Theranos is now retracting blood-test results from its Edison machines due to potential errors.
John Carreyrou leads the coverage of Theranos for the Wall Street Journal and spoke with Kai Ryssdal.
News and information you need, from a source you trust.
In a world where it’s easier to find disinformation than real information, trustworthy journalism is critical to our democracy and our everyday lives. And you rely on Marketplace to be that objective, credible source, each and every day.
This vital work isn’t possible without you. Marketplace is sustained by our community of Investors—listeners, readers, and donors like you who believe that a free press is essential – and worth supporting.